Why ME/CFS Patients Cannot Tolerate Stimulation: An Integrated Model
A defining yet under-theorized feature of ME/CFS is the global intolerance of stimulation—not only physical exertion, but also sensory input (light, sound, touch, chemical exposure), cognitive demands, and emotional stress. Healthy individuals process these stimuli automatically, below the threshold of conscious effort; ME/CFS patients experience them as profoundly depleting, painful, or both. This section synthesizes the mechanisms described throughout this chapter into a unified model explaining stimulus intolerance.
1 The Energy–Stimulus Bottleneck
All stimulus processing requires cellular energy. Visual processing imposes substantial ATP demands on retinal photoreceptors and visual cortex; auditory processing requires sustained ion-channel activity in cochlear hair cells and tonotopic cortical circuits; even interoceptive filtering—the brain’s continuous monitoring of internal state—consumes metabolic resources. In health, these costs are negligible relative to total energy availability.
In ME/CFS, mitochondrial ATP synthesis is impaired (Chapter Energy Metabolism and Mitochondrial Function), cerebral blood flow is reduced (Chapter Neurological and Neurocognitive Dysfunction), and metabolic flexibility is compromised (Chapter Energy Metabolism and Mitochondrial Function). The combined effect is a drastically reduced energy envelope. Sensory processing that should be metabolically trivial now competes with basic homeostatic functions—maintaining posture, regulating temperature, supporting immune surveillance—for the same limited ATP pool. When incoming stimulation exceeds this reduced processing capacity, the system cannot buffer the excess, and symptoms emerge: the headache from fluorescent lighting, the cognitive collapse from a conversation, the crash after a medical appointment.
2 Central Sensitization: Lowered Thresholds for All Inputs
The energy bottleneck explains why stimuli cost more than they should; central sensitization explains why stimuli register more intensely. Neuroinflammation—driven by chronically activated microglia releasing TNF-\(\alpha\), IL-1\(\beta\), IL-6, and reactive oxygen species (Renz-Polster et al. 2022) (Nakatomi et al. 2014)—reduces inhibitory control in the central nervous system (Nijs et al. 2017). The descending inhibitory pathways that normally suppress irrelevant sensory signals are impaired: conditioned pain modulation is absent or blunted (Nijs, Meeus, et al. 2012), endogenous analgesia fails to activate after exertion (Nijs, Crombez, et al. 2012), and tenderness thresholds are uniformly lowered across all tissue types (Chen et al. 2025). This loss of descending inhibition is not limited to pain circuits—it extends to all sensory modalities, producing the photophobia, phonophobia, chemical sensitivity, and allodynia reported by 70–90% of patients (Jason et al. 2013).
The kynurenine pathway amplifies central sensitization further: neuroinflammation-driven IDO activation diverts tryptophan toward quinolinic acid, an NMDA receptor agonist that maintains dorsal horn wind-up and sustains the sensitized state (Section Kynurenine Pathway and Quinolinic Acid Excitotoxicity: The “Fog Machine”). NMDA receptor overactivation, in turn, drives calcium-dependent long-term potentiation of nociceptive and sensory circuits (Woolf 2011), making the threshold reduction self-perpetuating.
3 Microglial Activation as the Central Amplifier
Microglia occupy a pivotal position in the stimulus intolerance model because they simultaneously worsen both the energy deficit and the sensory amplification. Chronically reactive microglia:
Sustain neuroinflammation. Persistent release of pro-inflammatory cytokines maintains central sensitization, preventing recovery of normal sensory gating (Section Microglia Activation and Neuroinflammatory Fatigue).
Release glutamate. Microglial glutamate release contributes to excitotoxic stress, further lowering the threshold for neuronal activation and amplifying stimulus-evoked responses (Renz-Polster et al. 2022).
Impair astrocytic metabolic support. The neuroglial failure hypothesis proposes that reactive microglia disrupt the astrocyte–neuron lactate shuttle, reducing the metabolic support available for neural computation and making cognitive processing more energetically expensive (Renz-Polster et al. 2022).
Drive complement-mediated synaptic pruning. Sustained complement activation (C1q, C3) may eliminate synapses in prefrontal and sensory cortex, reducing the circuits available for efficient stimulus processing (Section Microglia Activation and Neuroinflammatory Fatigue). Complement dysregulation — elevated C4a, C3a activation fragments with component consumption — has been documented in ME/CFS both at rest and post-exertion (Chapter Immune System Dysfunction, Section HMGB1-S100A8/A9 Double-DAMP Synergy at TLR4/RAGE).
Perpetuate the mast cell–microglia loop. Bidirectional communication between mast cells and microglia creates a self-amplifying neuroinflammatory cycle: mast cell histamine and tryptase activate microglia, which release ATP and cytokines that degranulate mast cells (Section Mast Cell Mediators and Histaminergic Symptom Generation).
This convergence means that microglial activation simultaneously increases the metabolic cost of processing stimuli and lowers the intensity threshold at which those stimuli produce symptoms—a double penalty.
4 Failure of Inhibitory Brakes
Normal stimulus tolerance depends on active inhibitory mechanisms that gate, filter, and attenuate sensory signals. In ME/CFS, multiple inhibitory systems fail concurrently:
- Descending inhibitory pain modulation: Absent or blunted conditioned pain modulation, with possible injury to midbrain and medullary descending regulatory pathways (Chen et al. 2025).
- Endocannabinoid system: Clinical endocannabinoid deficiency removes CB1-mediated presynaptic inhibition and CB2-mediated immune suppression, allowing unbraked mast cell degranulation and neuroinflammatory amplification (Section Endocannabinoid Deficiency and Mast Cell Brake Failure).
- GABAergic tone: In animal models of neuroinflammation, shifts in chloride transporter expression (downregulation of KCC2) convert GABAergic inhibition to paradoxical excitation in sensitized circuits, further amplifying stimulus responses. Whether this mechanism operates in ME/CFS is not yet established, but persistent neuroinflammation provides the preconditions.
- Glymphatic clearance: Impaired waste clearance during disrupted slow-wave sleep allows accumulation of neurotoxic metabolites that sustain microglial reactivity (Section Glymphatic Dysfunction and Brain Waste Accumulation).
The simultaneous failure of these brakes means that even low-intensity stimulation reaches central processing circuits unattenuated, where it encounters sensitized neurons operating on a depleted energy substrate—a combination that produces symptom responses grossly disproportionate to the stimulus.
5 Why All Modalities Are Affected
The model explains why stimulus intolerance in ME/CFS is not modality-specific. Physical, sensory, cognitive, and emotional stimulation all converge on the same bottleneck:
- Physical exertion generates metabolic danger signals (lactate, succinate, extracellular ATP) that activate TLR4/NF-\(\kappa\)B and NLRP3 pathways (Section Metabolic Danger Signals and the Post-Exertional Malaise Mechanism), triggering the PEM cascade.
- Sensory stimulation (light, sound, touch, chemicals) enters through sensitized peripheral and central circuits with failed inhibitory gating, overwhelming reduced processing capacity.
- Cognitive effort imposes metabolic demands on prefrontal and hippocampal circuits already compromised by neuroinflammation, impaired astrocytic metabolic support, and possible complement-mediated synaptic loss.
- Emotional stress activates the sympathetic nervous system and HPA axis, both dysregulated in ME/CFS, triggering catecholamine-driven immune activation and cytokine release that feed back into the neuroinflammatory cascade.
All four modalities tax the same limited energy substrate and pass through the same sensitized, poorly gated neural circuits. This explains why patients often report that different types of stimulation are interchangeable in their capacity to trigger crashes: a noisy environment, a difficult conversation, physical activity, and emotional distress can each independently exhaust the patient, and combinations are multiplicatively worse.
6 The Interoceptive Amplification Layer
Superimposed on these peripheral and circuit-level mechanisms, the brain’s predictive processing system (Section Interoceptive Prediction Error and the Bayesian Brain Fog Framework) encodes accumulated evidence of metabolic insufficiency and sensory overload as an updated interoceptive model with increased precision weighting. This means the brain assigns greater salience to internal danger signals, amplifying the subjective experience of every stimulus. The interoceptive model is not generating false signals—it is faithfully tracking genuine physiological dysfunction—but the increased precision weighting creates a further multiplicative amplification: stimuli that are objectively more costly and subjectively more intense due to the mechanisms above are additionally flagged as high-priority threats by the predictive brain.
7 Clinical and Therapeutic Implications
This integrated model generates several predictions with direct clinical relevance:
Stimulus reduction is not optional. Environmental modification (dim lighting, quiet rooms, reduced cognitive demands, chemical-free spaces) is a mechanistically justified first-line intervention, not merely a comfort measure. It reduces the total energy cost of stimulus processing and prevents repeated activation of the sensitization–inflammation–PEM cascade.
Multi-mechanism treatment is required. Because stimulus intolerance arises from the convergence of energy depletion, central sensitization, microglial activation, and inhibitory brake failure, no single-target intervention is likely to be sufficient. Effective management requires addressing multiple nodes: pacing (energy), LDN or minocycline (microglia), PEA (endocannabinoid support), sleep optimization (glymphatic clearance), and antioxidant support (oxidative amplifiers).
Stimulus tolerance is a biomarker of disease state. Changes in the range and intensity of tolerable stimulation track the activity of the underlying pathophysiology. Widening tolerance indicates improvement in energy metabolism, neuroinflammation, or both; narrowing tolerance signals worsening, often before other symptoms become apparent.
Forced stimulation causes harm. Compelling patients to endure stimulation they cannot tolerate—whether through graded exercise, cognitive behavioral reframing of avoidance as maladaptive, or environments that exceed sensory capacity—risks triggering the PEM cascade and potentially worsening central sensitization through repeated activation of the neuroinflammatory cycle.